Skip to main content
SpringerLink
Log in

ART switching increases hospitalisations, AEs and costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2012 US dollars

Reference

  • Korsnes JS, et al. Antiretroviral Treatment Switching and Its Association With Economic Outcomes and Adverse Treatment Effects Among Commercially Insured and Medicaid-Enrolled Patients With HIV in the United States. Annals of Pharmacotherapy : 20 Jul 2016. Available from: URL: http://doi.org/10.1177/1060028016659888

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ART switching increases hospitalisations, AEs and costs. PharmacoEcon Outcomes News 759, 11 (2016). https://doi.org/10.1007/s40274-016-3276-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3276-x

Search

Navigation